MEDecision Names Ellen Donahue-Dalton Executive Vice President and Chief Marketing Officer

WAYNE, PA--(Marketwire - Apr 25, 2012) - MEDecision Inc., the leading provider in collaborative health management solutions, today announced that business and marketing veteran Ellen Donahue-Dalton will take on a permanent role with the company as Executive Vice President and Chief Marketing Officer. In this capacity, she will be responsible for solution development and strategic marketing initiatives, including product marketing, industry marketing, lead generation, and customer and brand experience. Donahue-Dalton has been a consultant to MEDecision since 2011, and her vision and strategic guidance have helped the company adapt and evolve in the rapidly transforming healthcare space.

"Ellen thrives on creating and packaging solutions to challenging market dynamics," said Deborah M. Gage, president and CEO of MEDecision. "In a room full of clinicians, technologists, marketers and salespeople, she brings people and ideas together, developing and executing on real opportunities to drive the business forward. We are so fortunate to be able to count on her as a permanent addition to our team."

Donahue-Dalton is actively involved in the healthcare arena, and has partnered with global, national, and emerging healthcare service and technology organizations to help define, segment, and penetrate markets, as well as build and deploy leading products. Prior to joining MEDecision, Donahue-Dalton founded and led the Dalton Marketing Group, where she served as a consultant and coach to high-growth organizations in verticals including healthcare, manufacturing, security and entertainment. Earlier, Donahue-Dalton served as vice president, worldwide marketing and divisional president of GTECH Corporation, a $1B+ (revenue) global systems, software and services provider, where she helped drive double-digit annual growth as part of that company's founding management team. During her career, Donahue-Dalton has worked with clients including Magellan Health, Ceridian, Group and Pension Administrators, Inc., Bloodhound Technologies, and GTESS Corporation.

A passionate supporter of innovation through entrepreneurialism, Donahue-Dalton has served on the board of Social Venture Partners - RI, a state affiliate of an international organization that helps non-profits grow revenue- and job-producing businesses. She continues to coach social entrepreneurs who are building world-changing businesses. Donahue-Dalton holds a B.S. from Dickinson College, an M.S. from Boston University, and has done post-graduate work at the Wharton School of the University of Pennsylvania.

About MEDecision
MEDecision's contribution to the healthcare industry is a powerful platform that delivers meaningful data to inform the most important healthcare transaction -- patient care. We start with a philosophy that patients, providers and payers are all driving towards better health outcomes and that this common interest dictates the need for collaborative working environments.

Then, we apply 23 years of experience, $85+ million in research and development and the strongest clinical knowledge to deliver the MEDecision collaborative health management platform, which includes Nexalign®, a health decision support service that applies analytics to information gathered from multiple sources to foster better business and clinical decisions on a patient's behalf; Alineo®, a health management platform for delivering outcome-driven case, disease, utilization and behavioral health management; and InFrame®, a set of tools to facilitate the health and performance management processes for physicians and accountable care organizations.

For more information, visit www.MEDecision.com.

MEDecision is a trademark of MEDecision, Inc. The MEDecision logo and product names are also trademarks or registered trademarks of MEDecision, Inc. Other product and brand names are trademarks of their respective owners.